| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/11/2013 | WO2013050419A1 Pharmaceutical compositions comprising 40 - o - ( 2 - hydroxy) ethyl - rapamycin |
| 04/11/2013 | WO2013050413A1 Methods for obtaining a population of regulatory t cells |
| 04/11/2013 | WO2013050375A1 Process for preparing 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1(r)-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one via a novel intermediate |
| 04/11/2013 | WO2013050341A1 Azabenzoxazine derivatives as crac modulators |
| 04/11/2013 | WO2013050339A1 Pharmaceutical compositions of antihypertensives |
| 04/11/2013 | WO2013050334A1 Cyclohexyl-4h,6h-5-oxa-2,3,10b-triaza-benzo[e]azulenes as v1a antagonists |
| 04/11/2013 | WO2013050270A1 Benzoxazine derivatives as crac modulators |
| 04/11/2013 | WO2013037985A8 Pharmaceutical combinations including anti-inflammatory and antioxidant conjugates useful for treating metabolic disorders |
| 04/11/2013 | WO2013026852A3 Derivatives of mecamylamine |
| 04/11/2013 | WO2013026558A3 Combined therapeutic agent |
| 04/11/2013 | WO2013025939A9 Compounds and methods for treating cancer by inhibiting the urokinase receptor |
| 04/11/2013 | WO2013022996A9 The utility of nematode small molecules |
| 04/11/2013 | WO2013022410A3 Production method for effervescent formulations comprising dexketoprofen |
| 04/11/2013 | WO2013022243A3 Novel biphenyl derivative or a pharmaceutically acceptable salt thereof, and pharmaceutical composition for preventing or treating inflammatory diseases or autoimmune diseases comprising same as an active ingredient |
| 04/11/2013 | WO2013019874A9 Vitamin b6 derivatives of nucleotides, acyclonucleotides and acyclonucleoside phosphonates |
| 04/11/2013 | WO2013018060A3 Micro-rnas and compositions comprising same for the treatment and diagnosis of serotonin-, adrenalin-, noradrenalin-, glutamate-, and corticotropin-releasing hormone- associated medical conditions |
| 04/11/2013 | WO2013016697A3 17-hydroxyprogesterone ester-containing oral compositions and related methods |
| 04/11/2013 | WO2013015599A3 Pharmaceutical composition for oral administration comprising bisphosphonic acid or its salt |
| 04/11/2013 | WO2013015535A3 Novel pyrimidine derivative and pharmaceutical composition including same as an active ingredient |
| 04/11/2013 | WO2013012662A3 Pharmaceutical compositions for rectal administration |
| 04/11/2013 | WO2013009142A3 Sustained/release pharmaceutical composition comripising choline alfoscerate or pharmaceutically acceptable salt thereof and method for manufacturing the same |
| 04/11/2013 | WO2013009102A3 Cartilage cell treating agent comprising collagen, hyaluronic acid derivative, and stem cell derived from mammal umbilical cord |
| 04/11/2013 | WO2013006854A9 Compositions and methods for treating enterobacteriaceae |
| 04/11/2013 | WO2013006548A3 Composition for use in treating and preventing inflammation related disorder |
| 04/11/2013 | WO2013006020A3 Composition comprising pyruvic acids for protecting nerve cells |
| 04/11/2013 | WO2013003669A3 Compositions, methods of use, and methods of treatment |
| 04/11/2013 | WO2013003629A3 Methods and compositions for inhibition of bone resorption |
| 04/11/2013 | WO2013002584A3 Combination of effective substances causing synergistic effects of multiple targeting and use thereof |
| 04/11/2013 | WO2013002578A3 Pharmaceutical composition for treating premature ejaculation and method for treating premature ejaculation |
| 04/11/2013 | WO2012177831A3 Compounds for treating peripheral neuropathies and other neurodegenerative disorders |
| 04/11/2013 | WO2012175798A3 Combination therapy |
| 04/11/2013 | WO2012174229A3 Methods for the synthesis and purification of deoxycholic acid |
| 04/11/2013 | WO2012170976A3 Compositions and methods for the production of pyrimidine and pyridine compounds with btk inhibitory activity |
| 04/11/2013 | WO2012170957A3 Retinoid-liposomes for enhancing modulation of hsp47 expression |
| 04/11/2013 | WO2012170952A3 Compounds for targeting drug delivery and enhancing sirna activity |
| 04/11/2013 | WO2012170720A3 Methods and compositions for treating brain cancer |
| 04/11/2013 | WO2012169938A3 Device and methods for the culturing, storage and cryopreservation of stem and differentiated cells of human and animal origin |
| 04/11/2013 | WO2012167237A3 Compounds having antiparasitic or anti-infectious activity |
| 04/11/2013 | WO2012166987A3 Liphagal enantiomers and their derivatives and precursors, and enantioselective methods of making the same |
| 04/11/2013 | WO2012158843A3 Kinase inhibitors |
| 04/11/2013 | WO2012153193A3 Protein-active agent conjugates and method for preparing the same |
| 04/11/2013 | WO2012129145A8 Nsclc combination therapy |
| 04/11/2013 | WO2012104788A3 Anti-angiogenic compounds, pharmaceutical compositions containing same, and use thereof |
| 04/11/2013 | WO2012100957A8 Inhibitors of branched-chain-aminotransferase-1 (bcat1) for the treatment of brain tumors |
| 04/11/2013 | WO2012042224A8 Pharmaceutical composition comprising deferasirox |
| 04/11/2013 | WO2012028922A8 Controlled release pharmaceutical compositions of milnacipran |
| 04/11/2013 | WO2011081861A3 Hair growth and / or regrowth compositions |
| 04/11/2013 | US20130090591 Localization of agents at a target site with a composition and an energy source |
| 04/11/2013 | US20130090539 Fluorochrome material and method for using the same |
| 04/11/2013 | US20130090516 Local Anesthesia By Magnet-Directed Concentration of Nanoparticle Conjugated Anesthetic |
| 04/11/2013 | US20130090478 Novel compounds as opioid receptor modulators |
| 04/11/2013 | US20130090389 Polyethylene Glycol Compositions for Controlling Relapse of Herpes Labialis, Herpes Genitalis, and Herpes Zoster |
| 04/11/2013 | US20130090388 Method of treating gaucher disease |
| 04/11/2013 | US20130090387 Stabilized compositions comprising a therapeutically active agent and an oxidizing preservative |
| 04/11/2013 | US20130090386 Lysine specific demethylase-1 inhibitors and their use |
| 04/11/2013 | US20130090384 Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid |
| 04/11/2013 | US20130090383 Stable pharmaceutical composition and methods of using same |
| 04/11/2013 | US20130090379 Compositions Comprising Enzyme-Cleavable Phenol-Modified Tapentadol Prodrug |
| 04/11/2013 | US20130090377 Composition comprising coumestrol or a bean extract containing coumestrol |
| 04/11/2013 | US20130090375 Virus-mediated delivery of bevacizumab for therapeutic applications |
| 04/11/2013 | US20130090371 Methods and compositions for inhibition of beta2-adrenergic receptor degradation |
| 04/11/2013 | US20130090370 Apoptosis inducer for cancer cell |
| 04/11/2013 | US20130090369 Transfection sheets and methods of use |
| 04/11/2013 | US20130090368 Therapeutic antisense oligonucleotide compositions for the treatment of inflammatory bowel disease |
| 04/11/2013 | US20130090366 Modulation of epidermal growth factor receptor ligands |
| 04/11/2013 | US20130090365 Antimycotic pharmaceutical composition |
| 04/11/2013 | US20130090362 Guanidinyl-substituted polyamides useful for treating human papilloma virus |
| 04/11/2013 | US20130090359 Method for treating a trpv1-mediated disease |
| 04/11/2013 | US20130090356 Compositions and methods for treatment of neuropsychological deficits |
| 04/11/2013 | US20130090355 Chemical agents for the prevention of inhibition or tumor metastasis |
| 04/11/2013 | US20130090354 Pharmaceutical Compositions and Administrations Thereof |
| 04/11/2013 | US20130090350 Combination Analgesic Employing Opioid Agonist and Neutral Antagonist |
| 04/11/2013 | US20130090347 Ethynyl derivatives |
| 04/11/2013 | US20130090344 Pharmaceutical compositions comprising 4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-y1)-1H-benzimidazol-2-y1]-1H-quinolin-2-one lactate monohydrate |
| 04/11/2013 | US20130090343 Methods for administering aripiprazole |
| 04/11/2013 | US20130090342 Biphenyl substituted 1,3-dihydro-benzoimidazol-2-ylideneamine derivatives |
| 04/11/2013 | US20130090341 Heterocyclic compounds |
| 04/11/2013 | US20130090333 Benzoxazine derivatives as crac modulators |
| 04/11/2013 | US20130090332 Ethynyl derivatives |
| 04/11/2013 | US20130090329 Methods and Compositions for the Treatment of Psychotic Disorders Through the Identification of the Olanzapine Poor Response Predictor Genetic Signature |
| 04/11/2013 | US20130090328 Compounds for the treatment and prophylaxis of respiratory syncytial virus disease |
| 04/11/2013 | US20130090324 Novel prolylcarboxypeptidase inhibitors |
| 04/11/2013 | US20130090322 Method of treating pancreatic cancer |
| 04/11/2013 | US20130090321 Method for treating brain cancer |
| 04/11/2013 | US20130090320 Method of treating prostate cancer |
| 04/11/2013 | US20130090318 Once-a-month method of contraception |
| 04/11/2013 | US20130090317 Prophylactic and post-acute use of progesterone in conjunction with its enantiomer for use in treatment of traumatic brain injuries |
| 04/11/2013 | US20130090316 Nasal Delivery Mechanism for Prophylactic and Post-Acute Use of Progesterone and/or its Enantiomer for Use in Treatment of Mild Traumatic Brain Injuries |
| 04/11/2013 | US20130090315 Prophylactic and post-acute use of progesterone to better outcomes associated with concussion |
| 04/11/2013 | US20130090313 pH DEPENDENT CARRIERS FOR TARGETED RELEASE OF PHARMACEUTICALS ALONG THE GASTROINTESTINAL TRACT, COMPOSITIONS THEREFROM, AND MAKING AND USING SAME |
| 04/11/2013 | US20130090312 Methods of use related to xerostomia |
| 04/11/2013 | US20130090309 Amino-pyridine-containing spleen tyrosine kinase (syk) inhibitors |
| 04/11/2013 | US20130090308 Compositions for the treatment of dry eye |
| 04/11/2013 | US20130090307 Baclofen and acamprosate based therapy of neurological disorders |
| 04/11/2013 | US20130090305 Method using a dietary supplement for healing or regressing symptoms of gastroesophageal reflux disease, gastritis and ulcers |
| 04/11/2013 | US20130090304 Compositions including triciribine and taxanes and methods of use thereof |
| 04/11/2013 | US20130090303 Agonists of PY2Y Receptor as a Treatment for Aortic Stenosis and Cardiovascular Calcification |
| 04/11/2013 | US20130090301 Agent for suppressing the formation of abnormal skin cells caused by exposure to light |
| 04/11/2013 | US20130090300 Inhibitors of influenza endonuclease activity and tools for their discovery |
| 04/11/2013 | US20130090299 Phosphonate analogs of hiv inhibitor compounds |